Range | Mean ± SD | F test | p value | ||||
---|---|---|---|---|---|---|---|
S. LDH | Malignant | 415–1390 | 1046.91 ± 225.03 | 39.795 | 0.001* | P1 | 0.001* |
TB | 410–870 | 643.33 ± 111.73 | P2 | 0.001* | |||
Others | 560–830 | 707.14 ±108.28 | P3 | 0.435 | |||
Pl. ADA | Malignant | 11–42 | 21.87 ± 6.39 | 138.064 | 0.001* | P1 | 0.001* |
TB | 35–107 | 71.88 ± 19.95 | P2 | 0.911 | |||
Others | 15–33 | 22.43 ± 6.00 | P3 | 0.001* | |||
Pleural fluid Lymphocytic count | Malignant | 50–100 | 67.47 ±13.10 | 0.156 | 0.856 | P1 | 0.581 |
TB | 50–90 | 69.21 ± 12.11 | P2 | 0.961 | |||
Others | 57–85 | 67.71 ± 8.96 | P3 | 0.782 | |||
Cancer ratio | Malignant | 16.6–97.5 | 52.43 ± 19.36 | 59.405 | 0.001* | P1 | 0.001* |
TB | 5.4–23.7 | 10.00 ± 5.04 | P2 | 0.003* | |||
Others | 21.8–44.7 | 32.89 ± 7.52 | P3 | 0.001* | |||
Cancer ratio plus | Malignant | 21.7–195 | 80.69 ± 35.88 | 42.355 | 0.001* | P1 | 0.001* |
TB | 6.8–43.1 | 14.78 ± 7.67 | P2 | 0.009* | |||
Others | 30.7–64.7 | 49.34 ± 12.71 | P3 | 0.006* | |||
Pl. CEA | Malignant | 86–780 | 246.40 ±147.66 | 37.926 | 0.001* | P1 | 0.001* |
TB | 2–31 | 12.71 ± 8.36 | P2 | 0.001* | |||
Others | 2–35 | 14.43 ± 11.52 | P3 | 0.972 | |||
Pl. IFN-ϒ | Malignant | 3.5–13.7 | 7.18 ± 2.74 | 68.072 | 0.001* | P1 | 0.001* |
TB | 132.5–1322.6 | 542.37 ± 337.67 | P2 | 0.991 | |||
Others | 3.8–9.1 | 6.34 ± 2.08 | P3 | 0.001* |